Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

PIKE GTPase are phosphoinositide‐3‐kinase enhancers, suppressing programmed cell deathPIKE GTPase are phosphoinositide‐3‐kinase enhancers, suppressing programmed cell death

View through CrossRef
Introduction The structure, tissue distribution and cellular localization of PIKEs Mitogenic PIKE‐S signaling in the nucleus Anti‐apoptotic function of PIKE‐L in neurons Role of PIKE‐L in merlin inhibited growth suppression Phosphoinositol lipids as a feedback regulator to PIKE‐L activation and translocation Anti‐apoptotic activity of PIKE‐A in cancers PIKE‐A as the physiological substrate of Fyn Perspective remarks AbstractPhosphoinositide‐3‐kinase enhancers (PIKE) are GTP‐binding proteins that posses anti‐apoptotic functions. The PIKE family includes three members, PIKE‐L, PIKE‐S and PIKE‐A, which are originated from a single gene (CENTG1) through alternative splicing or differential transcription initiation. Both PIKE‐S and PIKE‐L bind to phosphoinositide‐3‐kinase (PI3K) and enhance its activity. PIKE‐A does not interplay with PI3K. Instead, it interacts with the downstream effector Akt and promotes its activity. These actions are mediated by their GTPase activity. Because both PI3K and Akt are important effectors in the growth factor‐mediated signaling which triggers cellular growth and acts against apoptosis, PIKEs therefore serve as the molecular switch that their activation are crucial for growth factors to exert their physiological functions. In this review, the current understanding of different PIKE isoforms in growth factors‐induced anti‐apoptotic function will be discussed. Moreover, the role of PIKE in the survival and invasion activity of cancer cells will also be introduced.
Title: PIKE GTPase are phosphoinositide‐3‐kinase enhancers, suppressing programmed cell deathPIKE GTPase are phosphoinositide‐3‐kinase enhancers, suppressing programmed cell death
Description:
Introduction The structure, tissue distribution and cellular localization of PIKEs Mitogenic PIKE‐S signaling in the nucleus Anti‐apoptotic function of PIKE‐L in neurons Role of PIKE‐L in merlin inhibited growth suppression Phosphoinositol lipids as a feedback regulator to PIKE‐L activation and translocation Anti‐apoptotic activity of PIKE‐A in cancers PIKE‐A as the physiological substrate of Fyn Perspective remarks AbstractPhosphoinositide‐3‐kinase enhancers (PIKE) are GTP‐binding proteins that posses anti‐apoptotic functions.
The PIKE family includes three members, PIKE‐L, PIKE‐S and PIKE‐A, which are originated from a single gene (CENTG1) through alternative splicing or differential transcription initiation.
Both PIKE‐S and PIKE‐L bind to phosphoinositide‐3‐kinase (PI3K) and enhance its activity.
PIKE‐A does not interplay with PI3K.
Instead, it interacts with the downstream effector Akt and promotes its activity.
These actions are mediated by their GTPase activity.
Because both PI3K and Akt are important effectors in the growth factor‐mediated signaling which triggers cellular growth and acts against apoptosis, PIKEs therefore serve as the molecular switch that their activation are crucial for growth factors to exert their physiological functions.
In this review, the current understanding of different PIKE isoforms in growth factors‐induced anti‐apoptotic function will be discussed.
Moreover, the role of PIKE in the survival and invasion activity of cancer cells will also be introduced.

Related Results

Characterisation of a plant 3‐phosphoinositide‐dependent protein kinase‐1 homologue which contains a pleckstrin homology domain
Characterisation of a plant 3‐phosphoinositide‐dependent protein kinase‐1 homologue which contains a pleckstrin homology domain
A plant homologue of mammalian 3‐phosphoinositide‐dependent protein kinase‐1 (PDK1) has been identified in Arabidopsis and rice which displays 40% overall identity with human 3‐pho...
Epigenetic Remodeling in Human Coronary Artery Smooth Muscle Cell Phenotypic Switching
Epigenetic Remodeling in Human Coronary Artery Smooth Muscle Cell Phenotypic Switching
AbstractBackgroundSmooth muscle cell (SMC) dedifferentiation contributes to repair and remodeling, but also cardiovascular pathologies. To understand this plasticity, the epigeneti...
Small GTPase patterning: How to stabilise cluster coexistence
Small GTPase patterning: How to stabilise cluster coexistence
Abstract Many biological processes have to occur at specific locations on the cell membrane. These locations are often specified by the localised activity of small ...
Connectome and regulatory hubs of CAGE highly active enhancers
Connectome and regulatory hubs of CAGE highly active enhancers
AbstractEvidence indicates that enhancers are transcriptionally active. Herein, we investigated transcriptionally active enhancers by using cap analysis of gene expression (CAGE) c...
Phosphatidylinositol 3′-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase
Phosphatidylinositol 3′-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase
Serine phosphorylation of insulin receptor substrate-1 (IRS-1) has been proposed as a counter-regulatory mechanism in insulin and cytokine signalling. Here we report that IRS-1 is ...
KSHV genome harbors both constitutive and lytically induced enhancers
KSHV genome harbors both constitutive and lytically induced enhancers
Abstract Kaposi’s sarcoma-associated herpesvirus (KSHV) belongs to the gamma-herpesvirus family and is a well-known human oncogenic virus. In infected cells, the vi...
Prevalence of programmed death ligand-1 in patients diagnosed with non-small cell lung cancer in Lebanon
Prevalence of programmed death ligand-1 in patients diagnosed with non-small cell lung cancer in Lebanon
Introduction: Programmed death ligand-1 expression has been shown to be a good predictor of response to cancer therapy with checkpoint inhibitors. Its expressio...
Cancer and cell death
Cancer and cell death
Programmed cell death is an ordered and orchestrated cellular process that occurs in physiological and pathological conditions. Regulated programmed cell death is one of the mechan...

Back to Top